Notably, compared to HER2 expressing cells, the miRNA profile of p95HER2 cells was shifted toward that of basal subtype cancers, and overlapped highly with that previously identified for cancers with ERK1/2 hyperactivation36. The gene discussed is ERBB2; the disease is cancer.